A carregar...
Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib
It would be helpful to have factors that could identify patients who will, or will not, benefit from treatment with specific therapies. Ideally, these should be molecular‐based factors. When results with molecular‐based factors are disappointing, physicians often use clinical characteristics to make...
Na minha lista:
| Publicado no: | Mol Oncol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5543832/ https://ncbi.nlm.nih.gov/pubmed/19383314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2007.12.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|